Clinical Trials Browser

INDUSTRY × eribulin × Other solid neoplasm × Clear all

NCT01418677 2016-05-17

An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00908908 2012-03-09

A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors

Phase 1 Completed

6 enrolled 7 charts

Other solid neoplasm

Advanced Solid Tumors